Adenovirus News and Research

RSS
Adenoviruses most commonly cause respiratory illness; however, depending on the infecting serotype, they may also cause various other illnesses, such as gastroenteritis, conjunctivitis, cystitis, and rash illness. Symptoms of respiratory illness caused by adenovirus infection range from the common cold syndrome to pneumonia, croup, and bronchitis. Patients with compromised immune systems are especially susceptible to severe complications of adenovirus infection. Acute respiratory disease (ARD), first recognized among military recruits during World War II, can be caused by adenovirus infections during conditions of crowding and stress.
Heterologous prime-boost vaccination induces robust mucosal and systemic immunity against SARS-CoV-2

Heterologous prime-boost vaccination induces robust mucosal and systemic immunity against SARS-CoV-2

One billion doses of Oxford-AstraZeneca COVID-19 vaccine released

One billion doses of Oxford-AstraZeneca COVID-19 vaccine released

Start codon disruption with CRISPR-Cas9 gene editing prevents Fuchs’ corneal dystrophy in mice

Start codon disruption with CRISPR-Cas9 gene editing prevents Fuchs’ corneal dystrophy in mice

Cancer vaccine reduces tumor burden, improves survival in animal model of Lynch syndrome

Cancer vaccine reduces tumor burden, improves survival in animal model of Lynch syndrome

Risk of venous thrombosis is higher in SARS-CoV-2 infection than vaccination

Risk of venous thrombosis is higher in SARS-CoV-2 infection than vaccination

Prior SARS-CoV-2 infection enhances Johnson and Johnson Ad26.COV2.S vaccine immunogenicity

Prior SARS-CoV-2 infection enhances Johnson and Johnson Ad26.COV2.S vaccine immunogenicity

SARS-CoV-2 spike-specific antibodies induced in breast milk by COVID-19 vaccines

SARS-CoV-2 spike-specific antibodies induced in breast milk by COVID-19 vaccines

Study shows inhalable nanocatchers can protect lung cells against SARS-CoV-2

Study shows inhalable nanocatchers can protect lung cells against SARS-CoV-2

How SARS-CoV-2 vaccination symptoms differ from early COVID-19 symptoms

How SARS-CoV-2 vaccination symptoms differ from early COVID-19 symptoms

Study compares mRNA and adenovirus-based SARS-CoV-2 vaccines against variants of concern

Study compares mRNA and adenovirus-based SARS-CoV-2 vaccines against variants of concern

Advantages and challenges of intranasal vaccines to fight against COVID-19 infections

Advantages and challenges of intranasal vaccines to fight against COVID-19 infections

Study suggests COVID-19 vaccine confidence and hesitancy in the UK driven by trust, not misinformation

Study suggests COVID-19 vaccine confidence and hesitancy in the UK driven by trust, not misinformation

Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model

Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model

Gene therapy delivered into the brain may be safe, effective in treating rare neurological disorder

Gene therapy delivered into the brain may be safe, effective in treating rare neurological disorder

Initial SARS-CoV-2 vaccination response may predict BNT162b2 booster response, but not AZD1222

Initial SARS-CoV-2 vaccination response may predict BNT162b2 booster response, but not AZD1222

Durable antibody response at least 8 months following vaccination with J&J COVID vaccine

Durable antibody response at least 8 months following vaccination with J&J COVID vaccine

Researchers discover how vaccine-induced immune thrombotic thrombocytopenia happens

Researchers discover how vaccine-induced immune thrombotic thrombocytopenia happens

Intranasal COVID-19 vaccine developed from bacterial extracellular vesicle induces robust antibody response in preclinical trials

Intranasal COVID-19 vaccine developed from bacterial extracellular vesicle induces robust antibody response in preclinical trials

Is the SARS-CoV-2 delta variant threatening vaccine efficacy?

Is the SARS-CoV-2 delta variant threatening vaccine efficacy?

More evidence that mixing COVID-19 vaccines may help elicit a robust immune response

More evidence that mixing COVID-19 vaccines may help elicit a robust immune response